Primary Site >> Esophagus Cancer

Gene >> FCGR3A

  • 2000
  • 2011
  • 2018
Ref: Influence of multimodality therapy on the cellular immunity of patients with esophageal cancer.
PMID: 11005560
Ref: Locoregional cellular immunotherapy for patients with advanced esophageal cancer.
PMID: 11156218
Ref: Immunonutritional diet modulates natural killer cell activation and Th17 cell distribution in patients with gastric and esophageal cancer.
PMID: 21215924
Ref: H(2)O(2) production within tumor microenvironment inversely correlated with infiltration of CD56(dim) NK cells in gastric and esophageal cancer: possible mechanisms of NK cell dysfunction.
PMID: 21811786
Ref: Tribody [(HER2)2xCD16] Is More Effective Than Trastuzumab in Enhancing gammadelta T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells.
PMID: 29725336